InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Wednesday, 07/26/2017 3:40:56 PM

Wednesday, July 26, 2017 3:40:56 PM

Post# of 2099
Looking forward to the VB-111 combo announcement later this year and hope they consider more than lung. With all the failures in gbm, it looks like treatment is moving towards combo as well.

https://www.washingtonpost.com/news/to-your-health/wp/2017/07/26/these-experimental-treatments-target-brain-cancer-like-john-mccains/?utm_term=.d3912d2da5e0

Researchers say they are learning from the failures. They now believe, for example, that it will take a combination of treatments to make progress against the disease. One reason: Glioblastoma tends to have subpopulations of different cancer cells that require different lines of attack.

The immunotherapy approaches include checkpoint inhibitors, genetically engineered cellular therapies, vaccines and viruses that infect and kill cancer cells.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News